Overview
In health care, AI and related technologies (like machine learning) can be used to gain insight into a patient's medical history, present state, and potential future outcomes. Healthcare companies supporting patients or providers will leverage AI to provide specific, personalized insights based on an individual's current health status, lifestyle, behavior, and genetic information. Join our panel of experts for an evening exploring how data, AI and technology are redesigning healthcare.
Date : 27 August 2018
Time : 7:00pm 9:00pm
Venue : 32 Carpenter Street, Singapore 059911
Programme:
6:30pm - 7:00pm: Check-in & Networking
7:00pm - 7:45pm: Panel/Lighting Talks
7:45pm - 8:15pm: Q&A
8:15pm - 9:00pm: Networking
Speakers:
- Dr Yau Teng Yan(MBBS, MMed, FRCR),Chief Medical Officer, Holmusk
- Joey Chao,VP of Product, MyDoc
- Julien de Salaberry,CEO & Founder, Galen Growth Asia: The Asia HealthTech Builder
Dr Yau Teng Yan(MBBS, MMed, FRCR)
Chief Medical Officer,Holmusk
Dr Yau Teng Yan (MBBS, M.Med, FRCR) is Chief Medical Officer at Holmusk, a healthcare company that leverages technology and data science to deliver effective, engaging and scalable digital programmes for people living with chronic diseases like diabetes. His current work also includes a grant from the Ministry of Health on a technology-driven intervention programme for dementia prevention, and with the Health Promotion Board on a digital health coaching intervention for overweight & obese children.
Prior to Holmusk, Teng Yan was a practicing doctor for 7 years in several public hospitals in Singapore including Tan Tock Seng Hospital and Singapore General Hospital. He trained in diagnostic radiology and is a fellow of the Royal College of Radiologists (London). He has also worked at the Military Medicine Institute where he was involved in health policy decisions and health screening initiatives in the Singapore Armed Forces.
He is a big believer that technology and artificial intelligence will transform the delivery of healthcare, to achieve better outcomes, reduced costs and improved patient experience.
Joey Chao
VP of Product,MyDoc
Joey Chao oversees product management at MyDoc. He is a business technologist who hasworked with various B2B and B2C technology companies from Silicon Valley to China toSoutheast Asia.
Prior to MyDoc, he was based in Bangkok and Singapore, where he was responsible forproduct management for the China market at Agoda, a global online accommodationreservations provider, part of Booking Holdings. In China, he ran his own startup ininternational education and technology and also opened the development center forSugarCRM, a customer relationship management company based in Cupertino, California.
Before moving to Asia in 2008, Joey had several roles in the enterprise software industry inthe San Francisco Bay Area. He holds a Bachelor of Science from Stanford University inComputer Systems Engineering.
Julien de Salaberry
CEO & Founder,Galen Growth Asia: The Asia HealthTech Builder
Changing the world comes in many forms - I am a healthcare change catalyst and evangelist who challenges the status quo in healthcare whilst understanding the world in which healthcare providers and organizations function. I strongly believe that medicine and healthcare are being transformed driven by Deep Tech representing an unprecedented opportunity for better patient outcome in Asia. I am the Founder and CEO of Galen Growth Asia, whose mission it is to build a sustainable and vibrant HealthTech ecosystem across Asia by scaling digital health innovation through industry partnerships.
With over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co., I have a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. I gained extensive international business experience across Europe, Middle East and Asia.
In 2012, I founded The Propell Group, a boutique venture investor and advisory firm, based in Singapore, which focuses on HealthTech startups and growth companies.
I also co-founded the Global Cancer Research & Commercialisation Fund in 2016 to establish greater collaboration and open innovation between research institutes, research foundations and investors from all corners of the globe. The fund's goal is to harness technology and business model innovation to deliver superior financial returns and, most importantly, drive better outcomes for cancer patients.
I co-wrote iDisrupted (published in November 2014) which focused on creating an understanding of the IR4's significant technological changes which are just beginning to re-shape our daily lives. I am now co-writing its sequel where we will address how IR4 is changing society.
I am also a regular speaker on HealthTech / Digital Health Innovation and Disruption.
